Shay Capital’s Merck MRK Stock Holding History

Shay Capital’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-70,000	Closed	-$6.03M	–	370
2022 Q3	$6.03M	Buy	+70,000	New	+$6.25M	1.3%	10

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Shay Capital's MRK Position: Q2 2023 in Review

Shay Capital sold out of Merck (MRK) in Q2 2023, closing a stake of 4,411 shares — an estimated $469K sold.

Shay Capital first reported a position in MRK in Q1 2023 and held it in 1 quarter. The position peaked at $469K in Q1 2023. 3,255 funds tracked by Wall St. Rank hold MRK as of Q2 2023.

Shay Capital reported no remaining Merck position as of Q2 2023 after selling out during the quarter.
Shay Capital sold 4,411 Merck shares in Q2 2023, an estimated $469K.
Shay Capital first reported a position in Merck in Q1 2023 and held it in 1 quarter.
Shay Capital's Merck position peaked at $469K in Q1 2023.
3,255 funds tracked by Wall St. Rank held Merck as of Q2 2023.

Based on Shay Capital's 13F filing for Q2 2023, filed 14 Aug 2023.